09:38 AM EST - Oncolytics Biotech Inc : Today announced the voting results from its Annual General Meeting of Shareholders held on Thursday, June 16, 2022. A total of 40.43% of the issued and outstanding common shares of the Corporation were represented either in person or by proxy at the meeting. Additionally, James T. Parsons was elected to the Oncolytics Biotech Board of Directors. Oncolytics Biotech Inc
shares T.ONC are trading unchanged at $1.14.
